Resource
Library

Access a collection of clinical posters, publications, and educational resources that highlight the scientific foundation and clinical validation of Velacur.

Our Velacur™ resource library brings together the growing body of evidence that supports the use of Velacur as a non-invasive tool for evaluating liver health. Within this collection you will find peer-reviewed publications, scientific posters, and clinical brochures that highlight the technology’s performance, new features, and clinical utility.

These materials reflect years of collaboration with leading hepatologists and research groups, documenting the role of Velacur in assessing Chronic Liver Disease. From comparative studies to real-world validation, each piece underscores the importance of reliable, accessible measurements in advancing patient care.

Whether you are a clinician seeking data, a sponsor exploring trial readiness, or a researcher reviewing the latest findings, this library is designed to provide clear access to the science behind Velacur. Explore the sections below to view or download individual resources, or access the full set for comprehensive reference.

Accuracy of Velacur in Assessing MASLD and MASH Patients Using Biopsy as the Gold Standard

Diagnostics 2025

Deep Learning Based Shear Wave Detection and Segmentation Tool for Use in Point-of-Care for Chronic Liver Disease Assessments

Ultrasound in Medicine & Biology 2024

Methods and Validation of Velacur Determined Fat Fraction in Patients with MASLD

WFUMB Ultrasound Open 2024

Velacur ACE Outperforms FibroScan CAP for Diagnosis of MASLD

Hepatology Communications 2024

The Use of Nonivasive Velacur for Discriminating Between Volunteers and Patients with Chronic Liver Disease: A Feasability Study

International Journal of Hepatology 2024

For Investigational Use Only

Validation of Velacur Elasticity (S-WAVE) and Attenuation (ACE) Against MRE and MRI-PDFF in Patients with Clinically Diagnosed MASLD or MASH

ACG 2025

Velacur VDFF Outperforms FibroScan CAP in Assessment of Liver Steatosis in a Large Cohort of Patients with MASLD and MASH

DDW 2025

The Performance of Velacur Against Liver Biopsy for Assessing Fibrosis and Steatosis

NASHTag 2024

Probe to Capsule Distance Measured During Point of Care Liver Assessments

Canadian Liver Meeting 2024

Repeatability of Velacur on Volunteers and Patients: Same Patients, Same Day, Different Scanner

AASLD 2023

Repeatability Coeffecient of Velacur Scans in the Same Patient Taken at Least 2 Weeks Apart

ACG 2023

Velacur ACE Outperforms CAP for Liver Fat Quantification Using MRI PDFF as the Gold Standard

EASL 2023

Machine Learning Algorithm to Detect Shear Waves During Velacur Exams

NASHTag 2023

Comparison of Velacur and Fibroscan to Magnetic Resonance Imaging for Quantitative Assessment of Fibrosis and Steatosis in NAFLD

AASLD 2022

Accuracy of Velacur AI Powered Liver Guide in Identification of Liver

DDW 2022

Measurement Accuracy of Skin to Liver Capsule Distance with Velacur and Fibroscan

AASLD 2021

Liver Incytes: Assessment of Fibrosis and Steatosis in Patients and Healthy Volunteers

EASL 2020

Velacur: Initial Results in Discrimination of Patients and Healthy Volunteers Based on Fibrosis and Steatosis

AASLD 2020

3D ACE: Attenuation Coeffecient Estimation in 3D for the Detection of Hepatic Steatosis

AASLD 2018

SWAVE: Steady State Shear Wave Elastography for Fibrosis Evaluation in Liver Disease

EASL 2018

Velacur Reimbursement Guide

Velacur ONE Interpretation Guide

Velacur ONE Product Brochure

Velacur Determined Fat Fraction

Velacur vs Transient Elastography

CDC Case Study

White Paper - Velacur Shear Wave Absolute Vibro-Elastography

Velacur Patient Brochure

Velacur For MASH Treatment Eligibility

Velacur ONE Instructions for Use

Velacur ONE Troubleshooting Guide

Velacur ONE Set Up Guide

Velacur ONE Component Guide

Velacur ONE Troubleshooting Ultrasound Images

Velacur ONE Procedure Guide

Velacur ONE Organ Guide Settings

Wave Quality Guide